OnabotulinumtoxinA Interactions
There are 120 drugs known to interact with onabotulinumtoxinA, along with 3 disease interactions. Of the total drug interactions, 25 are major, and 95 are moderate.
- View all 120 medications that may interact with onabotulinumtoxinA
- View onabotulinumtoxinA disease interactions (3)
Most frequently checked interactions
View interaction reports for onabotulinumtoxinA and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Aleve (naproxen)
- Ambien (zolpidem)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Coenzyme Q10 (ubiquinone)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- Elmiron (pentosan polysulfate sodium)
- Emgality (galcanezumab)
- EpiPen (epinephrine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- Imitrex (sumatriptan)
- Iron Sulfate (ferrous sulfate)
- Linzess (linaclotide)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Nurtec ODT (rimegepant)
- Prilosec (omeprazole)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Topamax (topiramate)
- Tylenol (acetaminophen)
- Ubrelvy (ubrogepant)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
OnabotulinumtoxinA disease interactions
There are 3 disease interactions with onabotulinumtoxinA which include:
Report options
QR code containing a link to this page
More about onabotulinumtoxinA
- onabotulinumtoxinA consumer information
- Compare alternatives
- Reviews (493)
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: skeletal muscle relaxants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
